Keyword: Pacira Pharmaceuticals
Novartis has reupped with Recro Pharma's CMO for production of two drugs, plus other news.
Facing persistent manufacturing difficulties, U.S.-based Pacira will stop producing chemo drug DepoCyt, laying off some employees in the process.
A new FDA rule that would govern off-label marketing has drugmakers in a minor tizzy—and they're demanding that the agency set its change aside.
When Kristen Williams got a call from a former colleague about taking on the in-house legal work for Pacira, she knew generally what to expect if she got back into the biotech biome. The two had worked together before, at a biotech bought out by a larger drugmaker